Brielle Benyon

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

Treating myelofibrosis with Jakafi earlier has shown promise in improving both survival and symptom burden

The FDA agreed to review a supplemental Biologics License Application for Opdivo to treat stage 2B or C, fully resected melanoma.